跳转到主内容

非常抱歉,我们不完全支持您的浏览器。如果您可以选择,请升级到较新版本或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更高版本。如果您无法进行此操作且需要支持,请将您的反馈发送给我们。

全新设计的官网为您带来全新体验,期待您的反馈

Elsevier
通过我们出版

Embase Datasets for drug safety and pharmacovigilance

The most trusted biomedical literature for pharmacovigilance is now accessible via API.

Contact an Elsevier expert
Three pharma professionals discussing research findings in lab coats

Is your PV process effective?

Don't get left behind with your pharmacovigilance. Join the world's leading pharma and medical device companies in the switch to an AI-enabled process. Automate deduplication and train your models on better signal identification for a streamlined and revolutionary PV process.

Bring confidence to your ML-driven pharmacovigilance

Abstract gravity wave background - 3D rendered image.

Integrate Embase's gold-standard content with advanced AI to improve adverse event monitoring, better signal detection and streamlined pharmacovigilance workflows.

The world's leading source of biomedical and drug safety data

Two Female Scientists Working, Using Digital Tablet, Analysing Samples, Talking
  • Structured biomedical literature, extracted from 8.3k journals (including 3.3k not found in Medline)

  • Structured data extracted from FDA, EMA regulatory documents and literature articles

  • 2.8M extracted safety and adverse event data

Let's discuss your data needs for pharmacovigilance

Want to learn more about how the Embase API can integrate this trusted data into your automated workflows? Fill out the form below and an Elsevier expert will contact you soon to discuss how Embase Datasets can support your AI success.

有关您的信息
有关您的组织
How does your organization intend to use the Elsevier data? *